• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于阿霉素和紫杉醇共递送的脂质包被中空介孔二氧化硅纳米球:制备、缓释、细胞摄取及药代动力学

Lipid-coated hollow mesoporous silica nanospheres for co-delivery of doxorubicin and paclitaxel: Preparation, sustained release, cellular uptake and pharmacokinetics.

作者信息

Qiu Yang, Wu Chao, Jiang Jie, Hao Yanna, Zhao Ying, Xu Jie, Yu Tong, Ji Peng

机构信息

Department of pharmacy, Jinzhou Medical University, 40 Songpo Road, Linghe District, Jinzhou, Liaoning Province 121000, China.

Department of pharmacy, Jinzhou Medical University, 40 Songpo Road, Linghe District, Jinzhou, Liaoning Province 121000, China.

出版信息

Mater Sci Eng C Mater Biol Appl. 2017 Feb 1;71:835-843. doi: 10.1016/j.msec.2016.10.081. Epub 2016 Nov 1.

DOI:10.1016/j.msec.2016.10.081
PMID:27987779
Abstract

A carrier consisting of lipid-coated hollow mesoporous silica nanospheres (L-HMSN) was produced for the combination of the water-insoluble drug (paclitaxel, PTX) and the water-soluble drug (doxorubicin, DOX). DOX was adsorbed into the nanoscale hollow structure of the hollow mesoporous silica nanospheres (HMSN) by adsorption and PTX was wrapped in the phospholipid layer of the HMSN surface by lipid film hydration method. The characterization results showed that DOX and PTX were present in the nanopheres in an amorphous state. The loaded L-HMSN (DOX/PTX@L-HMSN) in vitro drug release showed a sustained release in phosphate buffered solution (PBS) at pH6.8 and 0.001%SDS. The cellular uptake experiment indicated that L-HMSN was successfully taken up by A549 cells. In addition, the combination of DOX and PTX in L-HMSN exhibited a marked synergistic effect in inhibiting the proliferation of A549 cells. The pharmacokinetic study demonstrated that L-HMSN could significantly improve the relative bioavailability of DOX and PTX. These results confirm that L-HMSN is a promising carrier for successful drug combination.

摘要

制备了一种由脂质包覆的中空介孔二氧化硅纳米球(L-HMSN)组成的载体,用于负载水不溶性药物(紫杉醇,PTX)和水溶性药物(阿霉素,DOX)。DOX通过吸附作用被吸附到中空介孔二氧化硅纳米球(HMSN)的纳米级中空结构中,PTX通过脂质膜水合法包裹在HMSN表面的磷脂层中。表征结果表明,DOX和PTX以无定形状态存在于纳米球中。负载的L-HMSN(DOX/PTX@L-HMSN)在pH6.8的磷酸盐缓冲溶液(PBS)和0.001%SDS中体外药物释放显示出缓释特性。细胞摄取实验表明L-HMSN成功被A549细胞摄取。此外,L-HMSN中DOX和PTX的组合在抑制A549细胞增殖方面表现出显著的协同作用。药代动力学研究表明,L-HMSN可以显著提高DOX和PTX的相对生物利用度。这些结果证实L-HMSN是一种成功进行药物组合的有前景的载体。

相似文献

1
Lipid-coated hollow mesoporous silica nanospheres for co-delivery of doxorubicin and paclitaxel: Preparation, sustained release, cellular uptake and pharmacokinetics.用于阿霉素和紫杉醇共递送的脂质包被中空介孔二氧化硅纳米球:制备、缓释、细胞摄取及药代动力学
Mater Sci Eng C Mater Biol Appl. 2017 Feb 1;71:835-843. doi: 10.1016/j.msec.2016.10.081. Epub 2016 Nov 1.
2
Development of drug-loaded chitosan hollow nanoparticles for delivery of paclitaxel to human lung cancer A549 cells.用于将紫杉醇递送至人肺癌A549细胞的载药壳聚糖空心纳米颗粒的研制。
Drug Dev Ind Pharm. 2017 Aug;43(8):1304-1313. doi: 10.1080/03639045.2017.1318895. Epub 2017 Apr 27.
3
Biodegradable Alginate-Chitosan Hollow Nanospheres for Codelivery of Doxorubicin and Paclitaxel for the Effect of Human Lung Cancer A549 Cells.可生物降解的海藻酸钠-壳聚糖空心纳米球用于阿霉素和紫杉醇的共递送,以影响人肺癌 A549 细胞。
Biomed Res Int. 2018 Jan 28;2018:4607945. doi: 10.1155/2018/4607945. eCollection 2018.
4
Redox and pH dual-responsive PEG and chitosan-conjugated hollow mesoporous silica for controlled drug release.用于控释药物的氧化还原和pH双重响应性聚乙二醇与壳聚糖共轭的中空介孔二氧化硅
Mater Sci Eng C Mater Biol Appl. 2016 Oct 1;67:26-33. doi: 10.1016/j.msec.2016.04.091. Epub 2016 Apr 28.
5
Mesoporous silica nanorods for improved oral drug absorption.介孔硅纳米棒用于改善口服药物吸收。
Artif Cells Nanomed Biotechnol. 2018 Sep;46(6):1132-1140. doi: 10.1080/21691401.2017.1362414. Epub 2017 Aug 8.
6
Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.三种介孔硅微球的简易合成及其作为药物载体的缓释性能。
Curr Drug Deliv. 2023;20(9):1337-1350. doi: 10.2174/1567201819666220616121602.
7
Hyaluronic acid and carbon dots-gated hollow mesoporous silica for redox and enzyme-triggered targeted drug delivery and bioimaging.用于氧化还原和酶触发的靶向药物递送及生物成像的透明质酸和碳点门控中空介孔二氧化硅
Mater Sci Eng C Mater Biol Appl. 2017 Sep 1;78:475-484. doi: 10.1016/j.msec.2017.04.059. Epub 2017 Apr 13.
8
Glutathione-sensitive hollow mesoporous silica nanoparticles for controlled drug delivery.谷胱甘肽敏感的中空介孔硅纳米颗粒用于控制药物递送。
J Control Release. 2018 Jul 28;282:62-75. doi: 10.1016/j.jconrel.2018.04.032. Epub 2018 Apr 19.
9
Delivery of miR-375 and doxorubicin hydrochloride by lipid-coated hollow mesoporous silica nanoparticles to overcome multiple drug resistance in hepatocellular carcinoma.脂质包被的中空介孔二氧化硅纳米颗粒递送miR-375和盐酸多柔比星以克服肝细胞癌中的多药耐药性
Int J Nanomedicine. 2017 Jul 24;12:5271-5287. doi: 10.2147/IJN.S135306. eCollection 2017.
10
Application of a lipid-coated hollow calcium phosphate nanoparticle in synergistic co-delivery of doxorubicin and paclitaxel for the treatment of human lung cancer A549 cells.脂质包被的中空磷酸钙纳米颗粒在协同共递送阿霉素和紫杉醇用于治疗人肺癌A549细胞中的应用
Int J Nanomedicine. 2017 Oct 31;12:7979-7992. doi: 10.2147/IJN.S140957. eCollection 2017.

引用本文的文献

1
Fabrication of a Dual-Targeted Liposome-Coated Mesoporous Silica Core-Shell Nanoassembly for Targeted Cancer Therapy.用于靶向癌症治疗的双靶向脂质体包被介孔二氧化硅核壳纳米组装体的制备
ACS Omega. 2023 Sep 12;8(38):34481-34498. doi: 10.1021/acsomega.3c02901. eCollection 2023 Sep 26.
2
Smart Targeted Delivery Systems for Enhancing Antitumor Therapy of Active Ingredients in Traditional Chinese Medicine.用于增强中药活性成分抗肿瘤治疗的智能靶向递送系统。
Molecules. 2023 Aug 8;28(16):5955. doi: 10.3390/molecules28165955.
3
Kinetics and Mechanism of Camptothecin Release from Transferrin-Gated Mesoporous Silica Nanoparticles through a pH-Responsive Surface Linker.
喜树碱通过pH响应性表面连接子从转铁蛋白门控介孔二氧化硅纳米颗粒中释放的动力学及机制
Pharmaceutics. 2023 May 25;15(6):1590. doi: 10.3390/pharmaceutics15061590.
4
Co-encapsulation of paclitaxel and 5-fluorouracil in folic acid-modified, lipid-encapsulated hollow mesoporous silica nanoparticles for synergistic breast cancer treatment.将紫杉醇和5-氟尿嘧啶共包封于叶酸修饰的脂质包封中空介孔二氧化硅纳米颗粒中用于协同治疗乳腺癌。
RSC Adv. 2022 Nov 14;12(50):32534-32551. doi: 10.1039/d2ra03718a. eCollection 2022 Nov 9.
5
The emergence of nanoporous materials in lung cancer therapy.纳米多孔材料在肺癌治疗中的出现。
Sci Technol Adv Mater. 2022 Jul 20;23(1):225-274. doi: 10.1080/14686996.2022.2052181. eCollection 2022.
6
Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy.通过还原/pH双重响应纳米载体共递送阿霉素和紫杉醇用于骨肉瘤治疗
Drug Deliv. 2020 Dec;27(1):1044-1053. doi: 10.1080/10717544.2020.1785049.
7
Folate functionalized pH-sensitive photothermal therapy traceable hollow mesoporous silica nanoparticles as a targeted drug carrier to improve the antitumor effect of doxorubicin in the hepatoma cell line SMMC-7721.叶酸功能化 pH 敏感光热治疗示踪空心介孔硅纳米粒子作为一种靶向药物载体,提高肝癌细胞系 SMMC-7721 中阿霉素的抗肿瘤效果。
Drug Deliv. 2020 Dec;27(1):258-268. doi: 10.1080/10717544.2020.1718801.
8
Biomimetic Cationic Nanoparticles Based on Silica: Optimizing Bilayer Deposition from Lipid Films.基于二氧化硅的仿生阳离子纳米颗粒:优化脂质膜双层沉积
Biomimetics (Basel). 2017 Oct 20;2(4):20. doi: 10.3390/biomimetics2040020.
9
Transferrin receptor-targeted HMSN for sorafenib delivery in refractory differentiated thyroid cancer therapy.转铁蛋白受体靶向 HMSN 用于索拉非尼在难治性分化型甲状腺癌治疗中的递送。
Int J Nanomedicine. 2018 Dec 6;13:8339-8354. doi: 10.2147/IJN.S187240. eCollection 2018.
10
Self-Assembled Antimicrobial Nanomaterials.自组装抗菌纳米材料。
Int J Environ Res Public Health. 2018 Jul 4;15(7):1408. doi: 10.3390/ijerph15071408.